Abstract
As screening for prostate cancer has become more common, the issues surrounding its diagnosis and treatment have grown more complex. This review surveys recent advances and controversies, including definition of risk factors, the role of screening, and current treatment strategies.
MeSH terms
-
Aged
-
Aged, 80 and over
-
Carcinoma in Situ / pathology
-
Humans
-
Male
-
Mass Screening
-
Middle Aged
-
Neoplasm Staging
-
Prostate-Specific Antigen / blood
-
Prostatic Neoplasms* / diagnosis
-
Prostatic Neoplasms* / epidemiology
-
Prostatic Neoplasms* / etiology
-
Prostatic Neoplasms* / prevention & control
-
Prostatic Neoplasms* / secondary
-
Prostatic Neoplasms* / therapy
-
Risk Factors
Substances
-
Prostate-Specific Antigen